Lund, Sweden, November 29, 2023. Hamlet BioPharma AB (publ), the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections,…
Read More
Aktieägarna i Hamlet BioPharma AB (”Bolaget”), org.nr 556568-8958, kallas härmed till extra bolagsstämma torsdagen den 14 december 2023 klockan 16:30 på High Court i Malmö…
Pressmeddelande Lund 27 november 2023 DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, DIREKT ELLER INDIREKT, I ELLER TILL AUSTRALIEN, BELARUS, HONGKONG, JAPAN, KANADA, NYA…
Aktieägarna i Hamlet BioPharma AB (”Bolaget”), org.nr 556568-8958, kallas härmed till årsstämma torsdagen den 14 december 2023 klockan 15:00 på High Court i Malmö med…
The company was presented by Catharina Svanborg and Jan Zetterberg. To view the presentation, please use the link bekow: https://youtu.be/zkZsCx0y1Qw?si=bFGMAkwqGrkXLOd3 The presentation is also available…
Hamlet Biopharma vill meddela att bolagets årliga bolagsstämma planeras att äga rum den 14 december 2023. Åsredovisning kommer att offentliggöras innan årsstämman enligt sedvanlig praxis….
Professor Gabriela Godaly is working with Hamlet BioPharma to develop a new therapeutic concept to combat tuberculosis through the use of a bactericidal peptide. The…
Hamlet BioPharma, the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, announces the results for the investigational drug…